| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.6 |